Related Experiment Video
Updated: May 25, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Pain and dementia: a diagnostic challenge.
A Lukas1, M Schuler, T W Fischer
1Stipendiat Forschungskolleg Geriatrie, Robert Bosch Stiftung, AGAPLESION Bethesda Klinik Ulm, Akademisches Krankenhaus der Universität Ulm, Ulm, Deutschland. albert.lukas@bethesda-ulm.de
Zeitschrift Fur Gerontologie Und Geriatrie
|January 27, 2012
Summary
Assessing pain in dementia patients is crucial. Behavioral pain assessment tools, like PAINAD and PACSLAC, are recommended for those with advanced dementia when self-reporting is not possible.
Area of Science:
- Gerontology
- Neuroscience
- Pain Management
Background:
- The global population is aging, leading to a rise in dementia prevalence.
- Co-occurring pain is common in individuals with dementia.
- Under-detection and under-treatment of pain in dementia are significant clinical issues.
Purpose of the Study:
- To review current knowledge on pain assessment in dementia.
- To identify challenges in pain assessment for dementia patients.
- To discuss potential solutions for improving pain management in this population.
Main Methods:
- A comprehensive literature search was conducted using the MEDLINE® database.
Main Results:
- Dementia progression impairs verbal communication, complicating pain recognition.
- Numerous pain assessment tools have been developed for dementia.
- The psychometric properties of existing pain assessment tools require further validation.
Conclusions:
- Prioritize self-report pain assessment in dementia when feasible.
- Utilize behavioral pain assessment tools (PAINAD for daily use, PACSLAC for periodic assessment) in advanced dementia.
- Integrate all available supplementary information to enhance pain assessment accuracy.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...